Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Net Asset Quality Index
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Net Asset Quality Index of 44.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥22.22 Billion minus total liabilities of CN¥12.36 Billion yields net assets of CN¥9.85 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Zhejiang Huahai Pharmaceutical Co Ltd (600521) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhejiang Huahai Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2000–2025)
This chart shows how Zhejiang Huahai Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 44.4%, representing net assets of CN¥9.85 Billion against total assets of CN¥22.22 Billion CNY. See Zhejiang Huahai Pharmaceutical Co Ltd (600521) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Zhejiang Huahai Pharmaceutical Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 44.0% | CN¥9.46 Billion | CN¥21.50 Billion | CN¥12.05 Billion | ▼ -0.5 pp |
| 2024 | 44.5% | CN¥9.02 Billion | CN¥20.26 Billion | CN¥11.24 Billion | ▲ +0.2 pp |
| 2023 | 44.4% | CN¥8.25 Billion | CN¥18.60 Billion | CN¥10.35 Billion | ▲ +1.7 pp |
| 2022 | 42.7% | CN¥7.75 Billion | CN¥18.15 Billion | CN¥10.41 Billion | ▼ -1.1 pp |
| 2021 | 43.8% | CN¥6.78 Billion | CN¥15.47 Billion | CN¥8.69 Billion | ▼ -8.0 pp |
| 2020 | 51.8% | CN¥6.72 Billion | CN¥12.99 Billion | CN¥6.27 Billion | ▼ -2.1 pp |
| 2019 | 53.9% | CN¥5.78 Billion | CN¥10.73 Billion | CN¥4.95 Billion | ▲ +13.3 pp |
| 2018 | 40.6% | CN¥4.21 Billion | CN¥10.37 Billion | CN¥6.16 Billion | ▼ -20.6 pp |
| 2017 | 61.1% | CN¥5.05 Billion | CN¥8.27 Billion | CN¥3.21 Billion | ▼ -6.9 pp |
| 2016 | 68.1% | CN¥4.58 Billion | CN¥6.73 Billion | CN¥2.15 Billion | ▲ +0.6 pp |
| 2015 | 67.5% | CN¥3.72 Billion | CN¥5.52 Billion | CN¥1.80 Billion | ▼ -5.0 pp |
| 2014 | 72.4% | CN¥3.27 Billion | CN¥4.51 Billion | CN¥1.24 Billion | ▲ +4.8 pp |
| 2013 | 67.6% | CN¥3.02 Billion | CN¥4.47 Billion | CN¥1.45 Billion | ▲ +7.0 pp |
| 2012 | 60.6% | CN¥1.95 Billion | CN¥3.22 Billion | CN¥1.27 Billion | ▲ +1.2 pp |
| 2011 | 59.4% | CN¥1.53 Billion | CN¥2.58 Billion | CN¥1.05 Billion | ▼ -4.8 pp |
| 2010 | 64.2% | CN¥1.32 Billion | CN¥2.05 Billion | CN¥735.92 Million | ▼ -5.7 pp |
| 2009 | 69.9% | CN¥1.21 Billion | CN¥1.74 Billion | CN¥522.98 Million | ▼ -2.8 pp |
| 2008 | 72.7% | CN¥1.10 Billion | CN¥1.52 Billion | CN¥414.51 Million | ▼ -4.5 pp |
| 2007 | 77.2% | CN¥975.52 Million | CN¥1.26 Billion | CN¥287.78 Million | ▼ -2.5 pp |
| 2006 | 79.7% | CN¥875.40 Million | CN¥1.10 Billion | CN¥222.66 Million | ▼ -2.6 pp |
| 2005 | 82.3% | CN¥802.34 Million | CN¥975.04 Million | CN¥172.70 Million | ▼ -5.4 pp |
| 2004 | 87.7% | CN¥785.53 Million | CN¥895.55 Million | CN¥110.03 Million | ▼ -0.8 pp |
| 2003 | 88.5% | CN¥685.42 Million | CN¥774.68 Million | CN¥89.27 Million | ▲ +56.0 pp |
| 2002 | 32.5% | CN¥80.56 Million | CN¥248.18 Million | CN¥167.62 Million | ▲ +0.2 pp |
| 2001 | 32.2% | CN¥72.15 Million | CN¥223.88 Million | CN¥151.72 Million | ▼ -4.4 pp |
| 2000 | 36.6% | CN¥65.23 Million | CN¥178.02 Million | CN¥112.79 Million | — |